Dr. Caterina Gallippi's lab at the University of North Carolina Chapel Hill focuses on developing advanced ultrasound technologies to improve the diagnosis and monitoring of serious health conditions. Their research aims to enhance breast cancer detection through a novel ultrasound method that assesses collagen organization in breast tissue and to monitor kidney transplant rejection without invasive procedures. By combining innovative imaging techniques with biomedical engineering, her lab addresses critical gaps in patient care and disease management.

Dr. Jonathan Robert Sukovich's lab focuses on non-invasive ultrasound therapies, particularly a method called histotripsy that uses sound waves to break down and remove tissue without surgery. By studying the sounds produced during this process, the lab aims to develop reliable ways to measure tissue damage during treatment to improve the safety and effectiveness of this technology. Their work is crucial for getting histotripsy approved for clinical use, which could greatly benefit patients needing tissue removal.

Dr. James D. Bryers' lab focuses on innovative vaccine delivery systems using injectable hydrogels. They aim to develop self-replicating mRNA vaccines specifically targeting Staphylococcus aureus, a dangerous bacteria responsible for severe infections. By creating biodegradable hydrogel depots, the lab seeks to improve vaccine efficacy and safety through a single injection method rather than repeated doses.

Dr. Henry Vanbrocklin's lab focuses on creating innovative ways to improve prostate cancer treatment using nanomedicines. They are developing a special type of drug that carries a PARP inhibitor to tumors more effectively and is linked with a molecular imaging tool to track its delivery. Their approach aims to enhance the effectiveness of prostate cancer therapies while minimizing side effects, potentially changing how patients are treated in the future.

Dr. Claire Isabelle Vanpouille-Box's lab studies glioblastoma, a challenging brain cancer, focusing on how radiation therapy affects tumor metabolism and immune responses. The lab investigates how glioblastoma cells change their metabolism to produce fatty acids and how this impacts the immune system, potentially leading to therapy resistance and tumor recurrence. By understanding these mechanisms, the research aims to find new ways to boost the immune response against these tumors after radiation treatment.

Dr. Bino Abel Varghese's lab at the University of Southern California focuses on improving early diagnosis of Alzheimer's disease and related dementias through advanced data analysis. The lab works on harmonizing large sets of complex multi-modal data to derive accurate biomarkers for these diseases. By integrating various data sources and using cutting-edge machine learning techniques, they aim to understand Alzheimer's pathology better, ultimately leading to more effective treatment strategies.

Dr. George Truskey's research lab focuses on understanding and developing therapies for Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic disorder that causes rapid aging in children. The lab utilizes in vitro models of human blood vessels made from induced pluripotent stem cells to study the disease's effects on vascular function and to explore potential genetic therapies using advanced gene editing techniques. This research aims to improve the treatment of HGPS and other rare diseases that lack sufficient patients for clinical trials.

Dr. Cecilia Giachelli's lab at the University of Washington is focused on understanding how and why calcium builds up in blood vessels and heart valves, a process known as vascular calcification. This condition can lead to serious heart issues, especially in older adults and those with diabetes or kidney disease. The lab investigates the biological processes and genetic factors involved in this calcification to identify potential treatments and biomarkers that can improve cardiovascular health and prevent complications.

Dr. Hanjoong Jo's lab at Emory University studies how changes in blood flow can lead to diseases like atherosclerosis. They investigate how certain proteins in blood vessel cells can be triggered by flow changes, causing those cells to become unhealthy and promote plaque buildup. This research aims to uncover new ways to prevent heart disease by understanding these mechanisms better.

Dr. Monica Venere's lab focuses on understanding a specific type of brain tumor called ependymoma, particularly those driven by the ZFTA-RELA fusion. These tumors are especially challenging to treat, and the lab is investigating a protein called FACT that is involved in maintaining the cancerous state of these tumors. By exploring how FACT contributes to tumor growth and its potential as a drug target, the lab aims to develop new therapies that could significantly improve patient outcomes.

Dr. Daniel B. Vigneron's lab at UCSF focuses on advancing imaging techniques for better detection and assessment of prostate cancer. They are developing innovative methods utilizing hyperpolarized carbon-13 MRI to monitor metabolic changes in tumors, especially in response to therapies like radiation. Their work aims to improve biopsy guidance and treatment planning, ultimately enhancing patient care in prostate cancer management.

Dr. Hugo Fernando Posada-Quintero's lab focuses on developing advanced methods to objectively measure visceral pain, particularly in patients suffering from Irritable Bowel Syndrome (IBS). The team aims to create a novel biomarker that combines data from various physiological measurements to aid in pain management and enhance treatment outcomes. This research is significant as it can lead to new non-drug therapies for managing IBS-related pain, improving the quality of life for many patients.

Dr. Pavithra Viswanath's lab at UCSF focuses on understanding the metabolism of brain tumors, particularly diffuse midline gliomas in children and adult gliomas with IDH mutations. The lab studies how certain metabolic processes, like glycolysis and citrate metabolism, impact tumor growth and immune response. By identifying vulnerabilities in tumor metabolism, the lab aims to develop new therapies and imaging techniques to improve survival and quality of life for patients with these aggressive cancers.

Dr. Andrei G. Vlassenko's research focuses on understanding brain metabolism, especially as it relates to aging and Alzheimer's disease. His lab uses advanced imaging techniques, like PET and MRI, to explore how the brain uses oxygen and glucose during mental tasks, and how this might change in older adults and those with cognitive impairments. The goal is to uncover the metabolic processes involved in brain health and disease, which could lead to new insights on preventing cognitive decline.

The research lab focuses on developing advanced diagnostic tools for early detection of head and neck cancers, especially in low-resource settings. They aim to create portable, easy-to-use devices that utilize novel nanotechnology to quickly identify cancer markers, improving outcomes for underserved communities. By integrating cutting-edge techniques in molecular analysis, the lab's work is designed to provide faster and more accurate cancer diagnostics, ultimately saving lives.

Dr. Naren Vyavahare's lab at Clemson University focuses on developing innovative therapies for aortic aneurysms, a serious cardiovascular condition. The research involves using nanoparticle systems to target and repair damaged vascular elastin, which is crucial for preventing aneurysm ruptures. By applying these therapies in preclinical models, the lab aims to create a non-invasive treatment that could change how these dangerous conditions are managed, potentially saving lives and improving patient outcomes.

Dr. Piotr Walczak's lab focuses on developing innovative strategies to combat chronic HIV infections, particularly within the brain. They are exploring the use of genetically engineered glial progenitor cells that can release neutralizing antibodies directly in the brain to tackle HIV reservoirs that are difficult to treat with conventional therapies. This research aims to improve the health of people living with HIV and address complications such as HIV-associated neurocognitive disorders.

Dr. Yajing Wang's research lab at the University of Alabama at Birmingham focuses on improving treatments for patients suffering from diabetic ischemic heart failure. By studying the role of specific cardiac proteins and cell therapies, the lab aims to engineer small extracellular vesicles that enhance heart protection in diabetic conditions. Their goal is to restore the heart's function by modifying the local microenvironment with advanced biomaterials.

Dr. Kang Wang's lab at UCSF focuses on improving the early detection and monitoring of metastatic colorectal cancer through advanced imaging technologies. The lab is developing an artificial intelligence system designed to analyze multiple CT scans over time, which will aid radiologists in identifying subtle changes in the disease, streamline their reporting process, and enhance patient outcomes. By automating data extraction and improving the interpretation of CT images, the lab aims to ease the burden on healthcare professionals and improve the accuracy of cancer diagnoses.

Dr. Yingxiao Wang's lab focuses on innovative approaches to cancer treatment and vascular disease. They develop cutting-edge technologies like wireless devices to enhance CAR T cell immunotherapy by activating these immune cells precisely at tumor sites. Additionally, their research integrates single-cell imaging and gene editing techniques to understand how blood flow affects endothelial cell function, aiming to find therapeutic targets for cardiovascular diseases.